tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Veracyte price target lowered to $28 from $29 at Morgan Stanley
PremiumThe FlyVeracyte price target lowered to $28 from $29 at Morgan Stanley
2M ago
Veracyte’s Strong Clinical Evidence and Market Growth Justify Buy Rating
Premium
Ratings
Veracyte’s Strong Clinical Evidence and Market Growth Justify Buy Rating
2M ago
Veracyte Inc’s Earnings Call Highlights Robust Growth and Strategic Milestones
Premium
Company Announcements
Veracyte Inc’s Earnings Call Highlights Robust Growth and Strategic Milestones
2M ago
Veracyte reports Q2 EPS 44c, consensus 30c
PremiumThe FlyVeracyte reports Q2 EPS 44c, consensus 30c
2M ago
BMNR, VCYT, ZG: Cathie Wood Buys $15M More of Ethereum-Linked Bitmine
Premium
Market News
BMNR, VCYT, ZG: Cathie Wood Buys $15M More of Ethereum-Linked Bitmine
2M ago
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
Premium
Market News
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
2M ago
Veracyte Inc. Reports Strong Q1 2025 Earnings
PremiumCompany AnnouncementsVeracyte Inc. Reports Strong Q1 2025 Earnings
5M ago
Veracyte price target lowered to $42 from $49 at UBS
Premium
The Fly
Veracyte price target lowered to $42 from $49 at UBS
5M ago
Veracyte’s Strong Performance and Promising Growth Opportunities Justify Buy Rating
Premium
Ratings
Veracyte’s Strong Performance and Promising Growth Opportunities Justify Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100